Coenzyme Q10 (CoQ10, CoQ10) is a key electron carrier in the mitochondrial electron transport chain (ETC) involved in ATP production. CoQ10 also acts as a potent lipid-soluble antioxidant, protecting cell membranes and LDL cholesterol from oxidative damage. While the body naturally synthesizes CoQ10, this ability declines significantly with age.
The Q-SYMBIO study (2014, JACC Heart Failure) is a landmark trial in CoQ10 cardiac health. This multicenter, randomized, double-blind trial enrolled 420 patients with moderate-to-severe heart failure who received daily supplementation of 300 mg CoQ10 for 2 years. Results showed a 50% reduction in major adverse cardiovascular events (MACE), a 43% reduction in cardiovascular mortality, and an 43% reduction in all-cause mortality.
Statins lower cholesterol synthesis by inhibiting HMG-CoA reductase, but they also suppress CoQ10 production (both share the same biosynthetic pathway). Approximately 10-25% of statin users experience muscle symptoms (myalgia, weakness). Supplementing with CoQ10 can significantly alleviate these side effects and improve adherence to statin therapy.
CoQ10 exists in two forms: ubiquinone (oxidized) and ubiquinol (reduced). Ubiquinol is the active form in the body, with 3–8 times higher bioavailability than ubiquinone. It is especially suitable for people over 40 years old (as the body's ability to reduce CoQ10 declines with age) and heart failure patients (who experience high oxidative stress and require more reduced CoQ10).
Dynas Group (Hong Kong) Co., Ltd. offers a mitochondrial energy complex (Ubiquinol-type CoQ0 + PQQ + NADH + Acetyl-L-Carnitine) in the Energy & Mitochondrial Series, with custom capsule and powder formulations available. The formula is designed around a comprehensive mitochondrial support strategy: electron transport + biogenesis + antioxidant defense.
